Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published November 17, 2022 | Supplemental Material
Journal Article Open

Optical Control of Translation with a Puromycin-Photoswitch

  • 1. ROR icon New York University
  • 2. ROR icon California Institute of Technology

Abstract

Translation is an elementary cellular process that involves a large number of factors interacting in a concerted fashion with the ribosome. Numerous natural products have emerged that interfere with the ribosomal function, such as puromycin, which mimics an aminoacyl tRNA and causes premature chain termination. Here, we introduce a photoswitchable version of puromycin that, in effect, puts translation under optical control. Our compound, termed puroswitch, features a diazocine that allows for reversible and nearly quantitative isomerization and pharmacological modulation. Its synthesis involves a new photoswitchable amino acid building block. Puroswitch shows little activity in the dark and becomes substantially more active and cytotoxic, in a graded fashion, upon irradiation with various wavelengths of visible light. In vitro translation assays confirm that puroswitch inhibits translation with a mechanism similar to that of puromycin itself. Once incorporated into nascent proteins, puroswitch reacts with standard puromycin antibodies, which allows for tracking de novo protein synthesis using western blots and immunohistochemistry. As a cell-permeable small molecule, puroswitch can be used for nascent proteome profiling in a variety of cell types, including primary mouse neurons. We envision puroswitch as a useful biochemical tool for the optical control of translation and for monitoring newly synthesized proteins in defined locations and at precise time points.

Copyright and License

Copyright © 2022 American Chemical Society

Acknowledgement

T.K. is supported by the NYU MacCracken Fellowship. J.M.thanks the National Cancer Institute (NCI) for a F99/K00award (K00CA253758). This research was supported by theNational Institutes of Health (NIH) grant NS122316 and theNYU Grossmann School of Medicine.

Conflict of Interest

The authors declare no competing financial interest.

Additional Information

The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/jacs.2c07374.

  • Puroswitch docking structures (PDB)
  • Experimental procedures and characterization data; photophysical characterization; computational docking; synthetic recommendations; and computational data (PDF)

Files

ja2c07374_si_002.pdf
Files (4.0 MB)
Name Size Download all
md5:cc2012e7af54fd840522c67d044856a5
2.5 MB Download
md5:8d3f0b6d59975f3d6348f264a2c3c3ad
1.5 MB Preview Download

Additional details

Created:
August 14, 2024
Modified:
August 14, 2024